Impact of Removing Nonprescription Codeine in Australia: Protocol for a Prospective Cohort Study

BACKGROUND: On February 1, 2018, Australia rescheduled codeine to a prescription-only medication. Many concerns were associated with this change, including increased financial costs, reduced service accessibility, the potential for poorer pain management, and a decline in physical and mental health...

Descripción completa

Detalles Bibliográficos
Autores principales: McCoy, Jacqui, Nielsen, Suzanne, Bruno, Raimondo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101496/
https://www.ncbi.nlm.nih.gov/pubmed/32167481
http://dx.doi.org/10.2196/15540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101496/
https://www.ncbi.nlm.nih.gov/pubmed/32167481
http://dx.doi.org/10.2196/15540

Ejemplares similares